Beyond the Cleanroom: How Service Platforms Are Powering the Next Wave of Cell & Gene Therapies
Over the past decade, the UK has made bold investments in advanced therapy medicinal products (ATMPs), betting on homegrown innovation to lead the next frontier in medicine. Between public funding initiatives and strategic infrastructure developments such as the expansion of GMP cleanroom space and the establishment of centres including Catapult’s Stevenage manufacturing hub, the UK…
